Additional file 1 of Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

Abstract

Table S1. Adverse events (treatment related or not) reported over the entire treatment duration (all patients, N = 28). Table S2. Characteristics and outcome of patient with lung cancer. (DOCX 31 kb